Grandis Pharmaceuticals Private Limited

Grandis Pharmaceuticals Private Limited - business services in Hyderabad, Telangana, India. Directors, charges & compliance details.
CIN U47720TS2024PTC188875 Incorporated 28 August 2024 ROC Hyderabad HQ Hyderabad, Telangana, India
Active Private Limited Company
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Company age
2 yrs
Est. 2024
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data
Registrar
Hyderabad
ROC office

About Grandis Pharmaceuticals Private Limited

Data last updated:

Grandis Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It was incorporated on 28 August 2024.

The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U47720TS2024PTC188875.

The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors Shravan Kumar Surabhi and Naveen Gannamaneni.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.

Company details

CIN U47720TS2024PTC188875
Registration Number 188875
Incorporation Date 28 August 2024
ROC Hyderabad
Listing Status Unlisted
Company Status Active

Contact details

Grandis Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana.

  • Registered Address
    H No 5 – 12/71 Plot No – 71, Jonna Bandaroad Old Alwal, Hyderabad, Telangana, India – 500010
Comprehensive company report
Grandis Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Grandis Pharmaceuticals Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2024-25
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Grandis Pharmaceuticals Private Limited, buy the company report.

Board of directors of Grandis Pharmaceuticals Private Limited

Grandis Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Shravan Kumar SurabhiDirector28 Aug 20242 Years 2 MonthsCurrent
Naveen GannamaneniDirector28 Aug 20242 Years 2 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Grandis Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Grandis Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Grandis Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Naveen Gannamaneni was appointed as Director on 28 Aug 2024.

AGM
Grandis Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Grandis Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Naveen Gannamaneni was appointed as Director.
Appointed
Shravan Kumar Surabhi was appointed as Director.
Incorporation
28 Aug 2024
Grandis Pharmaceuticals Private Limited was registered on 28 Aug 2024 with Roc Hyderabad & aged 2 years 2 months as per MCA records.

Frequently asked questions

Grandis Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. It was incorporated on 28 August 2024 (2+ years old) and is registered under CIN U47720TS2024PTC188875.

Grandis Pharmaceuticals has 2 current directors:

The latest financial statements of Grandis Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2025 are in the company report.

The CIN (Corporate Identification Number) of Grandis Pharmaceuticals is U47720TS2024PTC188875. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Grandis Pharmaceuticals was incorporated on 28 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Hyderabad.

Naveen Gannamaneni was appointed as Director on 28 Aug 2024. Shravan Kumar Surabhi was appointed as Director on 28 Aug 2024.

The registered office of Grandis Pharmaceuticals is at H No 5 – 1271 Plot No – 71, Jonna Bandaroad Old Alwal, Hyderabad, Telangana, India – 500010.

Grandis Pharmaceuticals can be reached at its registered office: H No 5 – 1271 Plot No – 71, Jonna Bandaroad Old Alwal, Hyderabad, Telangana, India – 500010.

Grandis Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Hyderabad.